Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Key words: LPS — Inflammation — Leukocyte traffic — Thalidomide  (1)
Materialart
Erscheinungszeitraum
Schlagwörter
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    Inflammation research 46 (1997), S. 392-397 
    ISSN: 1420-908X
    Schlagwort(e): Key words: LPS — Inflammation — Leukocyte traffic — Thalidomide
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract. Objective and Design: Thalidomide is very effective in the treatment of idiopathic aphthous stomatitis, characterized by recurrent focal intramucosal leukocytic vasculitis. The mode of action of thalidomide in this clinical entity may include inhibition of the extravasation of leukocytes. Therefore, we studied the effect of thalidomide on different steps of leukocyte migration by intravital microscopy.¶Material: Male Syrian golden hamsters were used.¶Treatment: Leukocyte migration in buccal mucosa of the hamster cheek pouch was elicited by the local application of lipopolysaccharide (LPS, 20 μg/ml) or murine tumor necrosis factor-α (muTNF-α, 10 ng/ml). (+)-Thalidomide (20–200 mg/kg i.p.) was administered 60 min before the local application of LPS or muTNF-α. Dexamethasone (2 × 1.0–10 mg/kg i.p.) was administered 18 h and 60 min before topical LPS application.¶Methods: The numbers of rolling, firmly adherent and migrating leukocytes were estimated by intravital microscopy up to 165 min after the topical applications of LPS or muTNF-α and evaluated by an interactive image analysis software.¶Results: Thalidomide (20–200 mg/kg i.p.) dose-dependently inhibited LPS-stimulated perivenular leukocyte migration by up to 87 ± 5% and muTNF-α-induced leukocyte migration by up to 78 ± 4%. Dexamethasone (2 ± 1.0–10 mg/kg i.p.) inhibited LPS-stimulated leukocyte migration by up to 85 ± 13%. (+)-Thalidomide (200 mg/kg i.p.) inhibited LPS-stimulated rolling by 80 ± 5% and reduced the number of firmly adherent leukocytes by about 40%. Dexamethasone (2 × 10 mg/kg i.p.) did not reduce the number of rolling leukocytes but inhibited leukocyte adherence by 72 ± 9%.¶Conclusions: These results show that (+)-thalidomide predominantly inhibits leukocyte rolling and thus differs from the glucocorticoid dexamethasone. The inhibition of LPS- or muTNF-α-induced leukocyte extravasation by thalidomide may account for some of its clinical activities.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...